Dustin S Sjuts insider trades: Revance Therapeutics (RVNC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dustin reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | RVNC | ↓ Sell | 9,211 | $5.04 | $46K | Direct | Mar 19, 2024 (1d) |
| Jun 9, 2023 | RVNC | ↓ Sell | 5,000 | $30.82 | $154K | Direct | Jun 13, 2023 (4d) |
| May 15, 2023 | RVNC | ↓ Sell | 21,015 | $34.55 | $726K | Direct | May 16, 2023 (1d) |
| Mar 9, 2023 | RVNC | ↓ Sell | 21,508 | $31.59 | $679K | Direct | Mar 9, 2023 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Dustin S Sjuts's insider trades
Dustin S Sjuts is President at Revance Therapeutics (RVNC). Since Mar 9, 2023, Dustin has reported no open-market purchases and 4 sales worth $1.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares withheld for taxes (16 filings), grants and awards (14 filings), other transactions (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RVNC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.